Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late ascending
US (SEER+NPCR) 1 12.1 (12.1, 12.2) N/A 45,944 64.0
South Dakota 6 13.2 (12.2, 14.3) 12 (2, 34) 138 70.4
Wisconsin 6 14.8 (14.4, 15.2) 1 (1, 4) 1,061 70.3
Maine 6 14.2 (13.4, 15.0) 3 (1, 16) 272 69.6
West Virginia 6 13.9 (13.2, 14.6) 5 (1, 17) 346 69.6
Kentucky 3 13.5 (13.1, 14.0) 7 (3, 18) 727 69.3
Iowa 3 14.7 (14.2, 15.3) 2 (1, 5) 566 69.2
Colorado 6 11.8 (11.4, 12.2) 34 (24, 38) 711 69.0
Ohio 6 13.3 (13.0, 13.5) 10 (6, 18) 1,916 68.8
Indiana 6 12.5 (12.2, 12.9) 22 (12, 31) 974 68.7
Maryland 6 12.2 (11.8, 12.6) 28 (18, 35) 857 68.7
North Carolina 6 12.2 (11.9, 12.5) 29 (20, 34) 1,485 68.7
Utah 3 12.5 (11.9, 13.1) 24 (9, 35) 339 68.7
Missouri 6 12.6 (12.3, 13.0) 20 (12, 29) 950 68.6
North Dakota 6 12.5 (11.5, 13.7) 23 (3, 40) 108 68.4
Idaho 3 13.1 (12.3, 13.8) 14 (3, 31) 258 68.1
Pennsylvania 6 13.8 (13.5, 14.1) 6 (3, 10) 2,301 67.9
Kansas 6 12.9 (12.3, 13.4) 17 (6, 30) 435 67.4
Delaware 6 12.4 (11.5, 13.3) 25 (6, 39) 155 67.0
Massachusetts 3 12.7 (12.4, 13.1) 18 (10, 28) 1,064 67.0
Michigan 6 13.0 (12.7, 13.3) 15 (7, 22) 1,606 66.9
Vermont 6 12.6 (11.6, 13.8) 19 (3, 39) 108 66.8
Georgia 3 11.9 (11.6, 12.2) 33 (24, 36) 1,317 66.4
California 3 11.9 (11.8, 12.0) 32 (26, 36) 5,110 66.2
Minnesota 6 14.1 (13.7, 14.5) 4 (1, 10) 929 66.0
Montana 6 11.7 (10.8, 12.5) 35 (16, 43) 161 65.9
Louisiana 3 12.3 (11.8, 12.7) 26 (15, 35) 656 65.7
Nebraska 6 13.2 (12.5, 13.9) 11 (3, 28) 295 65.6
Illinois 3 12.6 (12.3, 12.9) 21 (14, 28) 1,873 65.5
Oregon 6 11.9 (11.5, 12.4) 31 (20, 37) 612 65.5
Virginia 6 10.8 (10.5, 11.1) 41 (36, 43) 1,060 65.3
Oklahoma 6 11.1 (10.7, 11.6) 38 (33, 43) 507 64.1
Rhode Island 6 12.2 (11.4, 13.1) 27 (7, 40) 161 63.7
District of Columbia 6 9.3 (8.2, 10.4) 47 (40, 50) 62 63.5
Connecticut 3 13.4 (12.9, 13.9) 8 (3, 20) 613 63.4
Mississippi 6 10.7 (10.2, 11.2) 42 (36, 46) 369 63.3
South Carolina 6 10.2 (9.8, 10.6) 43 (40, 47) 631 63.3
Washington 5 12.1 (11.8, 12.5) 30 (19, 35) 1,035 63.2
Alabama 6 10.0 (9.6, 10.4) 45 (42, 48) 595 63.1
Alaska 6 11.0 (9.8, 12.2) 39 (17, 47) 79 61.9
New Hampshire 6 12.9 (12.2, 13.7) 16 (4, 34) 229 61.9
Tennessee 6 10.9 (10.6, 11.3) 40 (36, 43) 885 61.9
New York 3 13.1 (12.9, 13.3) 13 (7, 19) 3,101 61.2
Arizona 6 9.2 (8.9, 9.5) 49 (46, 49) 788 61.1
Arkansas 6 11.2 (10.7, 11.7) 37 (30, 43) 415 61.0
Hawaii 3 9.2 (8.6, 9.9) 48 (44, 49) 169 60.8
New Jersey 3 13.3 (13.0, 13.6) 9 (5, 18) 1,427 60.6
Texas 3 10.2 (10.0, 10.3) 44 (42, 47) 2,840 58.7
Wyoming 6 9.9 (8.9, 11.1) 46 (34, 49) 67 58.6
New Mexico 3 7.8 (7.3, 8.3) 50 (49, 50) 200 53.4
Florida 6 11.4 (11.2, 11.6) 36 (33, 39) 3,259 50.2
Puerto Rico 6 6.3 (5.9, 6.6) N/A 247 42.9
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/01/2022 5:43 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top